AB VISTA TO SHOW BENEFITS OF OPTIMISED ENZYME USE AT VIV ASIA

20 February 2015

AB Vista will demonstrate how to make the most of enzymes at this year’s VIV Asia exhibition on Booth G033, Hall 103, during the show from March 11-13.

The company will also host two seminars on the opening day, to be held in Room 216 at the Bangkok International Trade & Exhibition Centre. The first, at 2.30pm, features AB Vista’s Technical Director for Asia and the Pacific, Dr Usama Aftab, speaking about an approach to dietary non-starch polysaccharides.

The second, presented by the company’s Research Director, Dr Mike Bedford, will focus on superdosing of phytase as a means to improve profitability.

AB Vista’s Global Sales Director, Ari Kiviniemi, says that while superdosing may be a relatively new concept in Asia, it continues to gain momentum across the rest of the world.

Superdosing takes phytase use beyond simple nutrient release, by adding an optimised phytase such as Quantum Blue, at three to four times the standard dose; this destroys the majority of the phytate anti-nutrient found in feed.

“Research suggests that by 2019, superdosing could account for more than 30% of all tonnes treated with phytase globally, saving the industry billions through improved performance,” said Mr Kiviniemi.

During the show, AB Vista will also be conducting a quiz on its booth, aimed at testing attendees’ knowledge on enzymes for a chance to win an iPad mini. A cocktail reception will also be held on March 11 at 4.30pm.

To RSVP for the seminars, contact: Roxanne.chew@abvista.com

For more information, contact AB Vista on +44(0)1672 517 650 or info@abvista.com.

ends

Notes to editor:

AB Vista is a global supplier of micro-ingredients for the animal feed industry.

For further press information please contact Nic Daley or Mike Keeler on +44 (0)20 8647 4467.

ABV/078/15

Tags: